Litigation Details for Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)

Docket	⤷ Start Trial	Date Filed	2015-12-16
Court	District Court, D. Delaware	Date Terminated	2017-09-18
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To	Sherry R. Fallon
Parties	MYLAN PHARMACEUTICALS INC.
Patents	7,674,799; 7,674,800; 7,683,072; 9,073,933; 9,522,919
Attorneys	Eric R. Hunt
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2015-12-16				External link to document
2015-12-15	103		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,073,933; 9,522,919; . (Smith… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2015-12-15	132		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,073,933; 9,522,919. (Attachments… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2015-12-15	28		for infringement of the low-ABUK patents (U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072). The…’s U.S. Patent No. 9,073,933 (“the ’933 patent”) expires. (D.I. 1 at ¶ 32.) The ’933 patent is the only…799 patent, claims 30-34 and 76-79 of the ’800 patent, and claims 1, 4, and 5 of the ’072 patent were…prosecution of the ’933 patent for obviousness-type double patenting over the low-ABUK patents. (Br. 9-10.) According…that the ’933 patent claims “are not patentably distinct” from the invalid low-ABUK patent claims. (Id	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document